vimarsana.com
Home
Live Updates
Ipavibart
Live Breaking News & Updates on Ipavibart
AstraZeneca:Phase III Trial Of Sipavibart Met Main Goal In Preventing COVID-19 In Immunocompromised Patients
LONDON (dpa-AFX) - AstraZeneca's (AZN.L, AZN) sipavibart demonstrated a statistically significant reduction in the incidence of symptomatic COVID-19 compared to control (tixagevimab/cilgavimab
London
,
City-of
,
United-kingdom
,
More-such-health-news
,
Ihr-portfolio
,
Astrazeneca
,
Hase
,
Rial
,
Ipavibart
,
Ain
,
Oal